[144] Roivant Sciences Ltd. SEC Filing

Rhea-AI Filing Summary

Roivant Sciences Ltd. (ROIV) filed a Form 144 notifying a proposed sale of 316,182 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $4,741,054.24, scheduled approximately for 09/22/2025. The shares were reported acquired the same day via a stock option exercise and paid for in cash. The filing also discloses prior sales by Eric Venker totaling 883,818 shares across July–September 2025 with combined gross proceeds of $12,644,412.21. The notice includes the sellers representation there is no undisclosed material adverse information.

Positive

• Clear disclosure of the proposed sale amount, broker, and acquisition method (stock option exercise)
• Exercise paid in cash, indicating no financing or vendor consideration
• Brokered sale via Morgan Stanley, reflecting use of an established execution channel
• Three months of recent sales are fully disclosed, improving transparency

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider selling continued via option exercise and open-market trades; transaction sizes appear small relative to large outstanding share count.

The filing shows an option exercise and planned open-market disposition of 316,182 shares via Morgan Stanley, with prior disposals by the same person totaling 883,818 shares in the past three months. The use of a broker and cash payment for the exercise are routine. Given the disclosed outstanding share count of 682,881,743, each reported trade represents a small fraction of total shares outstanding, suggesting limited immediate dilution or market impact based on the filing alone.

Compliance/Risk Analyst

TL;DR: Filing is procedurally complete for Rule 144 notice; includes standard seller attestation about undisclosed material information.

The Form 144 contains the required broker identification, share amounts, acquisition method, and recent sale history for the reporting person. The sellers signature block includes the standard attestation regarding material non-public information and a criminal false-statement warning. There are no explicit compliance exceptions or disclosures of trading plans in the submitted content.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	316182	4741054.24	682881743	09/22/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/22/2025	Stock Option Exercise	Issuer			316182	09/22/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ERIC VENKER 7th Floor 50 Broadway London X0 SW1H 0DB	Common	09/19/2025	683818	10220412.21
ERIC VENKER 7th Floor 50 Broadway London X0 SW1H 0DB	Common	08/20/2025	100000	1172000.00
ERIC VENKER 7th Floor 50 Broadway London X0 SW1H 0DB	Common	07/21/2025	100000	1152000.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the ROIV Form 144 propose to sell?

The notice proposes sale of 316,182 common shares via Morgan Stanley Smith Barney LLC with aggregate market value $4,741,054.24.

How were the shares acquired according to the Form 144?

The filing states the shares were acquired on 09/22/2025 by stock option exercise and paid for in cash.

What recent insider sales does the filing disclose for ROIV?

Eric Venker sold 683,818 shares on 09/19/2025 for $10,220,412.21, and two prior sales of 100,000 shares each on 08/20/2025 and 07/21/2025 totaling $2,424,000.00.

What is the issuers reported number of outstanding shares in the filing?

The Form 144 lists 682,881,743 shares outstanding.

When is the approximate date of the proposed sale?

The filing lists the approximate sale date as 09/22/2025.